Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

25.3%

19 terminated/withdrawn out of 75 trials

Success Rate

73.2%

-13.3% vs industry average

Late-Stage Pipeline

16%

12 trials in Phase 3/4

Results Transparency

73%

38 of 52 completed trials have results

Key Signals

3 recruiting38 with results17 terminated

Enrollment Performance

Analytics

N/A

39(69.6%)

Phase 4

9(16.1%)

Phase 3

3(5.4%)

Phase 1

3(5.4%)

Phase 2

2(3.6%)

56Total

N/A(39)

Phase 4(9)

Phase 3(3)

Phase 1(3)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (75)

Showing 20 of 75 trials

NCT03900468Not ApplicableTerminated

Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)

Role: lead

NCT07106242Not ApplicableCompleted

Adaptive Deep Brain Stimulation (aDBS) Study (Early Adapter) Part II

Role: lead

NCT07456865Not ApplicableRecruiting

Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device

Role: lead

NCT07216976Not ApplicableRecruiting

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

Role: lead

NCT05200923Not ApplicableRecruiting

Pelvic Health Electrically Evoked Recording (PEER) 2 Study

Role: lead

NCT05775510Terminated

Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain

Role: lead

NCT05226286Not ApplicableCompleted

Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)

Role: lead

NCT05177354Not ApplicableCompleted

Medtronic Closed-Loop Spinal Cord Stimulation System

Role: lead

NCT04547712Not ApplicableCompleted

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease

Role: lead

NCT02844465Not ApplicableCompleted

Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)

Role: lead

NCT03763708Not ApplicableTerminated

SCS Research Study

Role: lead

NCT04506866Not ApplicableTerminated

InterStim Micro Post Market Clinical Follow-up Study (ELITE)

Role: lead

NCT06442410Not ApplicableCompleted

Comparison of DTM™ SCS Therapy Combined With Conventional Medical Management (CMM) to CMM Alone in the Treatment of Intractable Back Pain Subjects Without Previous History of Lumbar Spine Surgery

Role: lead

NCT06499220Not ApplicableCompleted

Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)

Role: lead

NCT01750242Completed

Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study

Role: lead

NCT04765735Not ApplicableCompleted

Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study

Role: lead

NCT00773019Completed

SynchroMed II Post-Approval Study

Role: lead

NCT04601454Not ApplicableCompleted

DTM (TM) Spinal Cord Stimulation (SCS) Study

Role: lead

NCT03761277Phase 4Completed

Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain

Role: lead

NCT02937688Completed

Deep Brain Stimulation (DBS) for Parkinson's Disease International Study

Role: lead